Targeting the TGF-Beta Superfamily With Extended Half-Life Antibodies to Enable Improved Quality of Weight Loss
Time: 4:10 pm
day: Day One
Details:
- Long half life antibodies can reduce dose volume and frequency without sacrificing efficacy
- Inhibition of myostatin can counter lean mass loss and potentially enable improved patient experience and outcomes
- Additional targets and combinations of targets within the TGF-beta superfamily can enable further improvements in weight loss quality
